Company Directory / Biotechnology Research

PrivateFor profitBiotechnology ResearchToronto, Ontario, Canada
Interface Biologics develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.
Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.
Size
11-50 people: larger than 33% of companies with a size listed. 7 people list it on LinkedIn.
Age
25 years old.
Reach
No web traffic ranking listed. 891 followers on LinkedIn.
BiotechnologyHealth CareMedical Device
Funding, as listed
$32M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Interface Biologics, Inc., field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Biotechnology Research in Canada.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.